QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer
Clinical trial NCT06917092 · RECRUITING
Trial details
- NCT number
- NCT06917092
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.